InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Krishnan Rajesh, Chief Technology Officer. Insider active across 1 companies, notably Oncternal Therapeutics, Inc.. In total, 2 disclosures have been published. The latest transaction was disclosed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
029,867 shares0
Common Stock
SEC:0001209191-22-001976·
029,867 shares0
Common Stock
SEC:0001209191-22-001976:0·
2 of 2 declarations
About Krishnan Rajesh
Rajesh Krishnan is Chief Technology Officer at Oncternal Therapeutics, Inc. He is responsible for the technical direction of the company, overseeing the development of new technologies and products. His expertise is essential for innovation and the success of Oncternal Therapeutics.
